Bell Potter downgrade 23 November 2015, page-132

  1. 31,523 Posts.
    lightbulb Created with Sketch. 2100
    And just as I have often observed that..... investments that induce high levels of investor stress and anxiety, invariably are ones that are associated with poor returns. And vice versa.

    A vague observation. Almost as good as I get the feeling that.

    How about instead of telling each other supermodel stories, you focus on the facts about MSB?
    The science? The imminent news flow? The remuneration from Japan aGVHD, likely to be matched by the US?

    Nada. Niet. Zero.

    "For the record, even if these bots/algos/shorters do operate in our market, I don't get bothered by them at all, because in the long run, the performance of the underlying business will determine the share price. All of these are simply noise to my ears."

    Does the development stage of the business, factor in at any point? It seems to have eluded madamswer in his years of psuedo analysis, which has never seriously looked at the biotechnology industry, nor what makes stem cell technology exceptional... it's all a bit to fuzzy wuzzy for him.

    Because MSB is an emerging biotech, first products going to market in early 2016. This little detail has whizzed by you both with your supermodels, and showers of mutual compliments. Mwah mwah and all that.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.41
Change
0.620(34.6%)
Mkt cap ! $3.084B
Open High Low Value Volume
$1.90 $2.48 $1.90 $58.82M 25.68M

Buyers (Bids)

No. Vol. Price($)
3 100915 $2.40
 

Sellers (Offers)

Price($) Vol. No.
$2.41 99 1
View Market Depth
Last trade - 16.12pm 18/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.